InvestorsHub Logo
Post# of 64576
Next 10
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: None

Wednesday, 12/13/2017 1:16:46 PM

Wednesday, December 13, 2017 1:16:46 PM

Post# of 64576
$TPIV $3.16 new HODs starting slow ascent with new CEO Peter Hoang. $TPIV new TNBC Clinical Trial underway with first recruit.


Multi-epitope Folate Receptor Alpha Peptide Vaccine, Sargramostim, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer



https://clinicaltrials.gov/ct2/show/NCT03012100?term=NCT03012100&rank=1


NCT03012100

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.